A reconsideration of acute beryllium disease

Environmental Health Perspectives

Volumn 117, Issue 8, 2009, Pages 1250-1256

  Cummings, Kristin J ^a   Stefaniak, Aleksandr B ^a   Virji, M Abbas ^a   Kreiss, Kathleen ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Acute; Beryllium; Beryllium disease; Granuloma; Hypersensitivity; Immune sensitization; Pneumonitis

Indexed keywords

BERYLLIUM;

ABSENTEEISM; ADULT; AIR SAMPLING; ANTIGEN RECOGNITION; ARTICLE; BERYLLIOSIS; BLOOD LEVEL; CASE REPORT; HUMAN; LUNG ALVEOLITIS; LUNG BIOPSY; LUNG FUNCTION; LUNG GRANULOMA; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MALE; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THORAX RADIOGRAPHY; WORK RESUMPTION;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; BERYLLIOSIS; BERYLLIUM; HUMANS; HYPERSENSITIVITY; MALE; RADIOACTIVE POLLUTANTS; RESPIRATORY SYSTEM; SKIN; YOUNG ADULT;

EID: 69249100931     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800455     Document Type: Article

References (62)

1. Amicosante M, Fontenot AP. 2006. T cell recognition in chronic beryllium disease. Clin Immunol 121:134-143.
2. Balmes JR. 2005. Chronic beryllium disease and cobalt-related interstitial lung disease. In: Textbook of Clinical Occupational and Environmental Medicine (Rosenstock L, Cullen MR, Brodkin CA, Redlich CA, eds). 2nd ed. Philadelphia:Elsevier Saunders, 357-363.
3. Becklake MR, Cowie RL. 2000. Pneumoconioses. In: Textbook of Respiratory Medicine (Murray JF, Nadel JA, Mason RJ, Boushey HA, eds). 3rd ed. Philadelphia:WB Saunders, 1811-1851.
4. Burkhart CG. 2006. Irritant-induced enhancement of induction and elicitation of sensitization for the treatment of seborrheic keratoses. Int J Dermatol 45:1240-1242.
5. Business Wire. 2005. Brush Wellman Receives $9 Million Contract Award from Department of Defense toward New Primary Beryllium Facility. Available: http://www.businesswire.com/portal/site/google/ ?ndmViewId=news_view&newsId=20051201005636&newsLang=en [accessed 17 November 2008].
6. Butnor KJ, Sporn TA, Ingram P, Gunasegaram S, Pinto JF, Roggli VL. 2003. Beryllium detection in human lung tissue using electron probe microanalysis. Mod Pathol 16:1171-1177.
7. Churg A, Green FHY. 1998. Diseases caused by metals and related compounds. In: Pathology of Occupational Lung Disease. 2nd ed. Baltimore, MD:Williams and Wilkins, 77-128.
8. Cordeiro CR, Jones JC, Alfaro T, Ferreira AJ. 2007. Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 28:504-513.
9. Curtis GH. 1951. Cutaneous hypersensitivity due to beryllium: a study of thirteen cases. AMA Arch Derm Syphilol 64:470-482.
10. Curtis GH. 1959. The diagnosis of beryllium disease, with special reference to the patch test. AMA Arch Ind Health 19:150-153.
11. Day GA, Hoover MD, Stefaniak AB, Dickerson RM, Peterson EJ, Esmen NA, et al. 2005. Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model. Exp Lung Res 31:341-360.
12. DeNardi JM. 1959. Long-term experience with beryllium disease. AMA Arch Ind Health 19:110-116.
13. DeNardi JM, Van Ordstrand HS, Carmody MG. 1949. Acute dermatitis and pneumonitis in beryllium workers. Ohio State Med J 45:567-575.
14. DeNardi JM, Van Ordstrand HS, Curtis GH, Zielinski J. 1953. Berylliosis: summary and survey of all clinical types observed in a twelve-year period. AMA Arch Ind Hyg Occup Med 8:1-24.
15. Diaz-Sanchez D, Rumold R, Gong H Jr. 2006. Challenge with environmental tobacco smoke exacerbates allergic airway disease in human beings. J Allergy Clin Immunol 118:441-446.
16. Dutra FR. 1948. The pneumonitis and granulomatosis peculiar to beryllium workers. Am J Pathol 24:1137-1165.
17. Eisenbud M. 1982. Origins of the standards for control of beryllium disease (1947-1949). Environ Res 27:79-88.
18. Eisenbud M. 1998. The standard for control of chronic beryllium disease. Appl Occup Environ Hyg 13(1):25-31.
19. Eisenbud M, Berghout CF, Steadman LT. 1948. Environmental studies in plants and laboratories using beryllium: the acute disease. J Ind Hyg Toxicol 30:281-285.
20. Finch GL, Mewhinney JA, Eidson AF, Hoover MD, Rothenberg SJ. 1988. In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J Aerosol Sci 19:333-342.
21. Freiman DG, Hardy HL. 1970. Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol 1:25-44.
22. Hardy HL. 1951. The character and distribution of disease in American industries using beryllium compounds. Proc R Soc Med 44(3):257-262.
23. Hardy HL. 1965. Beryllium poisoning - lessons in control of man-made disease. N Engl J Med 273(22):1188-1199.
24. Hazard JB. 1959. Pathological changes of beryllium disease: the acute disease. AMA Arch Ind Health 19:179-183.
25. Kent MS, Robins TG, Madl AK. 2001. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl Occup Environ Hyg 16(5):539-558.
26. Kim Y, Jee Y, Park J, Lee K, Lee S. 2004. Acute beryllium disease in liquid metal workers [Abstract]. Eur Respir J 24(48 suppl):P981.
27. Kleinman MT, Sioutas C, Froines JR, Fanning E, Hamade A, Mendez L, et al. 2007. Inhalation of concentrated ambient particulate matter near a heavily trafficked road stimulates antigen-induced airway responses in mice. Inhal Toxicol 19(suppl 1):117-126.
28. Kreiss K, Day GA, Schuler CR. 2007. Beryllium: a modern industrial hazard. Annu Rev Public Health 28:259-277.
29. Kreiss K, Miller F, Newman LS, Ojo-Amaize EA, Rossman MD, Saltini C. 1994. Chronic beryllium disease - from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol 71:123-129.
30. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. 1997. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605-612.
31. Kroschwitz JI, Howe-Grant M, eds. 1992. Kirk-Othmer Encyclopedia of Chemical Technology, Vol 4. 4th ed. New York:John Wiley and Sons.
32. Machle W, Beyer E, Gregorius F. 1948. Berylliosis: acute pneumonitis and pulmonary granulomatosis of beryllium workers. Occup Med 5:671-683.
33. Maier LA. 2001. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg 16:514-520.
34. McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A. 2004. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 46:95-103.
35. Middleton DC, Lewin MD, Kowalski PJ, Cox SS, Kleinbaum D. 2006. The BeLPT: algorithms and implications. Am J Ind Med 49(1):36-44.
36. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. 1991. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 88:54-60.
37. National Research Council. 2008. Managing Health Effects of Beryllium Exposure. Washington, DC:National Academies Press, 25-39.
38. Newman LS, Maier LA. 2003. Beryllium disease. In: Interstitial Lung Disease (Schwarz MI, King TE, eds). 4th ed. Hamilton, Ontario, Canada:BC Decker, 440-441.
39. Newman LS, Mroz MM, Balkissoon R, Maier LA. 2005. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171:54-60.
40. Rees PJ. 1979. Unusual course of beryllium lung disease. Br J Dis Chest 73(2):192-194.
41. Sawyer RT, Abraham JL, Daniloff E, Newman LS. 2005. Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas. J Occup Environ Med 47:1218-1226.
42. Sawyer RT, Maier LA, Kittle LA, Newman LS. 2002. Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol 2:249-261.
43. Scott BL, McCleskey TM, Chaudhary A, Hong-Geller E, Gnanakaran S. 2008. The bioinorganic chemistry and associated immunology of chronic beryllium disease. Chem Commun (Camb) (25):2837-2847.
44. Shima S. 1971. Hygienic control of beryllium [in Japanese]. Rodo no Kagaku 26(6):36-46.
45. Smith HR, Basketter DA, McFadden JP. 2002. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 27:138-146.
46. Stefaniak AB, Chipera SJ, Day GA, Sabey P, Dickerson RM, Sbarra DC, et al. 2008. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment. J Toxicol Environ Health A 71(22):1468-1481.
47. Stefaniak AB, Day GA, Hoover MD, Breysse PN, Scripsick RC. 2006. Differences in dissolution behavior in a phagolysosomal stimulant fluid for single-component and multi-component materials associated with beryllium sensitization and chronic beryllium disease. Toxicol In Vitro 20:82-95.
48. Stefaniak AB, Hoover MD, Day GA, Dickerson RM, Peterson EJ, Kent MS, et al. 2004. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit 6:523-532.
49. Stefaniak AB, Hoover MD, Dickerson RM, Peterson EJ, Day GA, Breysse PN, et al. 2003. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease. Am Ind Hyg Assoc J 64:297-305.
50. Sterner JH, Eisenbud M. 1951. Epidemiology of beryllium intoxication. AMA Arch Ind Hyg Occup Med 4:123-151.
51. Sutton M, Burastero SR. 2003. Beryllium chemical speciation in elemental human biological fluids. Chem Res Toxicol 16:1145-1154.
52. Tepper LB, Hardy HL, Chamberlin RI. 1961. Toxicity of Beryllium Compounds. Elsevier Monographs on Toxic Agents, Vol 13. Amsterdam:Elsevier.
53. U.S. Department of Energy. 2008. International Energy Outlook 2008. DOE/ EIA-0484. Washington, DC:Energy Information Administration. Available: http://www.eia.doe.gov/oiaf/ieo/pdf/0484(2008).pdf [accessed 30 June 2009].
54. Van Ordstrand HS, Hughes CR, DeNardi JM, Carmody MG. 1945. Beryllium poisoning. JAMA 129:1084-1090.
55. Vorwald AJ. 1948. Pathological aspects of acute pneumonitis and pulmonary granulomatosis in beryllium workers. Occup Med 5:684-689.
56. Waksman BH. 1959. The diagnosis of beryllium disease, with special reference to the patch test: discussion of paper by Dr. Curtis. AMA Arch Ind Health 19:154-156.
57. White DW, Burke JE. 1955. The Metal Beryllium. Cleveland, OH:American Society for Metals.
58. Wichmann HE. 2007. Diesel exhaust particles. Inhal Toxicol 19(suppl 1):241-244.
59. Williams WJ. 1977. Beryllium disease - pathology and diagnosis. J Soc Occup Med 27:93-96.
60. Williams WJ. 1988. Beryllium disease. Postgrad Med J 64:511-516.
61. Williams WJ, Wallach ER. 1989. Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis and other granulomatous diseases. Sarcoidosis 6:111-117.
62. Zhang L, Tinkle SS. 2000. Chemical activation of innate and specific immunity in contact dermatitis. J Invest Dermatol 115:168-176.